Search research articles
Contact Us
Filters
Showing results (141-150 of 159) with videos related to
Page
of 16
Sort By:
Nature Communications
|
March 18, 2024
Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation
Sébastien Thériault, Zhonglin Li, Erik Abner, et al.
CJC Open
|
March 12, 2020
Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography
Audrey-Anne Després, Nicolas Perrot, Anthony Poulin, et al.
Ebiomedicine
|
July 6, 2024
Polygenic inheritance and its interplay with smoking history in predicting lung cancer diagnosis: a French-Canadian case-control cohort
Véronique Boumtje, Hasanga D Manikpurage, Zhonglin Li, et al.
The Pharmacogenomics Journal
|
December 6, 2019
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
Roelof A J Smit, Stella Trompet, Aaron Leong, et al.
JAMA
|
March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
S Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Journal of the American College of Cardiology
|
May 4, 2019
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
Kang H Zheng, Sotirios Tsimikas, Tania Pawade, et al.
JAMA Cardiology
|
July 17, 2024
Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis
Benoit J Arsenault, Krithika Loganath, Arnaud Girard, et al.
Journal of the American College of Cardiology
|
August 2, 2014
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
S Matthijs Boekholdt, G Kees Hovingh, Samia Mora, et al.
Atherosclerosis
|
May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
Florian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Circulation
|
August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
S Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 159) with videos related to
Sort By:
Page
of 16
Nature Communications
|
March 18, 2024
Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation
Sébastien Thériault, Zhonglin Li, Erik Abner, et al.
CJC Open
|
March 12, 2020
Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography
Audrey-Anne Després, Nicolas Perrot, Anthony Poulin, et al.
Ebiomedicine
|
July 6, 2024
Polygenic inheritance and its interplay with smoking history in predicting lung cancer diagnosis: a French-Canadian case-control cohort
Véronique Boumtje, Hasanga D Manikpurage, Zhonglin Li, et al.
The Pharmacogenomics Journal
|
December 6, 2019
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
Roelof A J Smit, Stella Trompet, Aaron Leong, et al.
JAMA
|
March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
S Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Journal of the American College of Cardiology
|
May 4, 2019
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
Kang H Zheng, Sotirios Tsimikas, Tania Pawade, et al.
JAMA Cardiology
|
July 17, 2024
Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis
Benoit J Arsenault, Krithika Loganath, Arnaud Girard, et al.
Journal of the American College of Cardiology
|
August 2, 2014
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
S Matthijs Boekholdt, G Kees Hovingh, Samia Mora, et al.
Atherosclerosis
|
May 15, 2023
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
Florian Kronenberg, Samia Mora, Erik S G Stroes, et al.
Circulation
|
August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
S Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Page
of 16